1-alkyl-2-acetyl-sn-glycerol
10-cell
10-eo-cfu
28-day mortality
8-fluo-camp binding
95% confidence interval
95% confidence level
abdominal problems
aberrant reactivation
abnormal body composition
abnormal ca(2+) handling
abnormal cardiac t2
abnormal exercise
abnormal hr variability
abnormal liver texture
abnormal scn5a mrna splicing
absolute risk
absorption function
accounting
acetylcholinesterase inhibitor pyridostigmine
acquired heart failure
acs procedures
actin cytoskeleton pathways
activated neurohormonal systems
activating myocardial pde2
activation
activators
active
acute anthracycline-induced cardiotoxiciteit
acute autonomic nervous system modulation
acute care hospital
acute decompensated hf
acute heart failure clinical trials
acute heart failure trials
acute hf diagnosis
acute hf trials
acute hospital facilities
acute pulmonary embolism
acute treatment
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adenoviral vector
adherence
adjunctive treatment
adjusted ankle-brachial index
adjusted hazard ratio
administratie
administratie databases
admission median
admission nt-probnp
admission to discharge
adult medicine
adults
advanced chronic obstructive pulmonary disease
advanced chronic organ failure
advanced copd
advanced disease
advanced heart failure
advanced heart failure therapy
adverse event rates
aerobic
aerobic capacity
aerobic exercise training
aerobic training
af at risk
af patients
af type
af-free probability
afterload burden
age
age- and sex-adjusted risk
age-dependent effect
aggressive dose uptitration
aggressive medical treatment
aggressive protocols
aim
air pollution
akt
akt→forkhead box
albumin concentration
albumin level
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
alendronate-
algorithms
all-cause
allopurinol rats
alphalisa immunoassays
altered protein kinase
altered regulation
alternatieve treatments
ambient air pollution
ambulatory heart failure trial
ambulatory hf
ambulatory icd patients
ambulatory patients
american
ami admission
ami mortality rates
ami patient
amino-terminal
amyloidotic pattern
an
anabolic imbalance
anaesthesia
anemia treatment
anestized dogs
ang ii infusion mouse
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
animals
ann arbor veterans' affairs hf clinic
annular size reduction
ans
ans mice
antagonizing excessive β-ar drive
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline treated survivors
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer patients
anti-inflammatory effects
antiarrhythmic medication
antibodies targeting nonglycosylated
antibodies targeting the extreme n
antihypertensive medication use
anxiety
aortic blood flow
aortic pressure curve
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical
apical rotation
appendicular lean mass index
arg16/ gln27
aric hf
aric hf model
arrhythmia events
arrhythmia substrate
arrhythmia-related costs
artificial pulse
as
asymptomatic pediatric fontan
atheromatous coronary disease
athletes
atp demand
atp production rates
atrial explant-derived c-kit+ cells
atrial structure
atropine infusion
attention control
augmented cyclic guanosine monophosphate
augmented feedback
automatic defibrillator implantation
autonomic modulation
autopsy samples
avd variation
b
b treatment
b-treated
barriers
barriers to exercise
basal
basal contractility
basal rotations
baseline echocardiography
baseline electrocardiogram
baseline glomerular filtration rate
baseline hgb
baseline hrqol
bb dose
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt interval
beat-to-beat qt intervals
behavioural-change
benefit
best quintile
bet bromodomain-containing protein 4
bet inhibition
beta-blocker dose
beta-blocker therapy
bhlh transcription factor
binding
bioinformatic analysis
biomarker studies
biomarker-guided clinical trial
biomedical reasons
biomedical treatment
bisphosphonate users
black ethnicity
black patients
black race
blacks
blinded core laboratory
blood loss
blood pressure control
blood testing
blood work drawn
blood-flow paths
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
bnp level
bnp levels
bnp measurements
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
borderline
both geometry
bottleneck stent model
bound to hdl
bradycardia induced
bradycardic response
brd4)
breast cancer patients
breath due to lung congestion
breath-holding
breathing control
bridge to recovery
bridging therapy
bromodomain inhibition halts heart failure
bt
budget
burden
c d hf
c-kit+ cell differentiation
c-kit+ cell phenotype
c-kit+ cell yield
c57b
ca(2+) transient
ca(2+)-uptake
ca2
cachectic heart failure patients
calf muscle
california office of statewide healthplanning and development patient discharge
caloric restriction
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
canadian
canadian cardiovascular society guidelines
canadian special access programme
cancer
cancers
candesartan in heart failure assessment
carbohydrates
cardiac autonomic
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-kit
cardiac centre
cardiac comorbidities
cardiac development
cardiac diameters
cardiac energy metabolism
cardiac explant c-kit+ progenitors
cardiac explant-derived cells
cardiac failure survey
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac insulin-resistance
cardiac irs1
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1 mapping
cardiac mena deletion
cardiac metabolic
cardiac mrna levels
cardiac myocyte-specific mena overexpression
cardiac nurse
cardiac nurses
cardiac pathogenes
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac procedures
cardiac risk
cardiac sodium current
cardiac specialty hospital
cardiac surgery patients
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac symptoms
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiology-cardiovascular surgery consensus report heart failure
cardiomyocyte-like cells
cardiomyopathic restriction to flow
cardiomyopathy origin
cardioprotective effect
cardiopulmonary exercise
cardiotoxiciteit
cardiovascular complications
cardiovascular conditions
cardiovascular event rate
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular reason
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
cardiovascularverter defibrillator-crt
care management
carotid baroreflex activation therapy
carotid bodies
carotid intima-media
caspase 3 expression
caspase-3 activity
caspase-3 gene expression
catalytic
catecholamine infusions
catheter system
catheter-based revascularization
caucasian
cause mortality
cav1.3 channels
cd133
cdp
cell expansion protocols
cells isolated
cells overexpressing
cellular responses
centers for medicare
centrale venous pressure
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf devices
cf lvad patients
cha2ds2vasc score
channels
charm programme
chart review
chelation choices
chelation regimens
chemical instability
chemotherapy-induced heart failure
chf atrial explants
chf inhibition
chf patients
chf patients intubated
chf predictive model
chf treatments
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
childhood malignant disease
children
chinese herbal medicine
chm
choline
cholinephosphotransferase
chromatin remodeling
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic advanced heart failure patients
chronic disease
chronic hf-ref
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology collaboration equation
chronic stable guideline-directed medical therapy
chronic β-ar stimulation
chronically instrumented new zealand white rabbits
circulating cd34
circulating forms
circulating fragments
circulating mediator
circulating nt-probnp
circulating nt-probnp concentration
circulating plasma ne
circulatory arrest
circulatory derangement
circumferential shortening
class i
class i recommendations
class ii heart failure
class iii
clcnka gg genotype
clcnka polymorphism
clcnka snp
clin
clinical burden
clinical composite response
clinical deterioration
clinical doppler echocardiography
clinical excellence registry
clinical modification codes
clinical outcome
clinical prediction rule
clinical trial registries
clinical trials
closure
cmf-inv
cms metrics
co correlated
co-activating transcription factor networks
co-morbidity burden
cochrane databases
cochrane effective practice
cogeneration
cognitive function
cognitive impairment
collagen density
colon
comanagement
combinatied care management
community outpatient settings
competing risk
competitive collateral growth
complicating ami
computed tomographic angiography
computing readmissions
concordance c statistics
concurrent hf
conditional gene-targeted hand2 mice
conduction abnormalities
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congenital lesions
congestive heart failure exacerbation
congestive heart failure patients
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
congestive symptoms
conscious
conscious dogs
conscious hf rats
consenting ambulatory hf patients
contemporary heart failure
content-driven telehealth system
content-driven telehealth technology
contextual factors
continuous nris
continuous wave
contrast agent
control
control adenovirus
control group
controlled for death
controlled randomized trials
controlled trial investigating outcomes in exercise training
controlled trial investigating outcomes of exercise training
controlling heart rate
cost
cost-effective
cost-effectiveness
costs
coupling
cox
cox model analysis
cox proportional hazards
cpet guiding exercise rehabilitation
cpg recommendations
cpg-recommended pharmacological treatment
cr group
creatine kinase
creatine kinase activity
credible interval
cronbach
cross-talk between the heart
crt capability
crt implantation
crt off
crt on
crt on assignment
crt response
crt-d recipients
crude
crude 28-day case-fatality rate
crude rates
crude rr
cultured cardiomyocytes
cumulative administration
cumulative urine volume
curve
cutoff
cutoff level
cutoff value
cv deaths
cv events
cxl-1020 converts
cxl-1020) isolated myoctyes
cystatin c level
cytotoxic effect
danish heart failure database
dapc protein levels
dash diet scores
data monitoring board
deactivation
death/all-cause readmission
debilitating chronic disease
debilitating stroke
decongestion
decongestion end point
decoy vegf receptor
decreasing albumin levels
decrement
defects
defibrillator-only therapy
deficits
degradation
delayed rhythm control
dementia
depressed left ventricular
depression
depressive symptoms
deranged ca(2+) handling
derivation cohort
descriptive
desensitizes
detectable change
detergent
development and evaluation
device
device consideration
device implantation
device therapies
devices
diabetes status
diabetic zsf1 rats
diagnosti performance
diagnosti procedure
diagnosti procedures
diagnostic approaches
diagnostic performance
diagnostic test
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic mitral flow velocity
diastolic properties
dichotomized patients
died
diet
diet group
diet score
diet scores
dietary interventions
dietary patterns
differentiation
diffuse myocardial changes
dilated poorly contracting ventricles
diminished cyclic adenosine monophosphate
direct renin inhibitors
disappearance
discharge diagnosis
discharge patients
discharged alive
discharged patients
disclosing prognosis
discrimination
discrimination improvement
disease management
disease management programs in heart failure
disease progression
disease recapitulates
disease-specific costs
diseased human
distressing implantable cardioverter-defibrillator shocks
disturbed intestinal barrier
dithiothreitol
diuretic effect
diuretic efficacy
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic therapy
donor
doppler imaging
dose uptitration
dose-related gradient
double mutant
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc
doxorubicin in vitro
doxorubicin-induced heart failure
driveline infection
driveline injury
drs deciles
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug-free
dyn s/cm(5)
dynamic
dynamic resistance training
e gfr
e-lateral
e-septal
e-septal correlated
e/e
e/e'lateral
e/e'mean
e/emean
e/eseptal
early diastolic mitral
early diastolic mitral annular velocity
early diastolic mitral annulus velocity
early diastolic mitral flow velocity
early diastolic mitral mitral annular velocity
early medical management
early rhythm control therapy
early transmitral blood flow velocity
early transmitral flow
early treatment
early-onset hf
ec coupling
ec/elateral
ecb
eccentric versus concentric left ventricular hypertrophy
ecct patients
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiographic substudy
echocardiographic systolic parameters
ecmo group
ecmo+vad group
ecmo+vad groups
economic analysis
economic climate
economic evaluations
economic impact
economic models
economische
ed patients
ed physicians
ed visit
ed visits
ed volume
effect
effective treatment
efficiency
egfr group ii
egfr group iii
egfr group iv
ejection
elastic n2 bus segment
elderly
elderly patients hospitalized
electric remodeling
electrical activation sequence
electrocardiographic device
electromechanical behavior
electronic databases
elektrial activation
elevated left atrial pressure
elevated resistin
eligibility
embryonic gene programs
emd prolongation
emergency
emergency cardiac catheterization
emotional status
emotional stress
emphasis-hf study
encoding truncated
end point of death
end stage heart failure heart failure
end-diastolic dimension
end-diastolic dimension index
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energie expenditure
energy deficit
energy transfer-based assays
enhanced catabolism
enos-ser
enos-thr
enrollment
epigenetic readers
eplerenone in mild patients hospitalization
erasers
erc induced recovery
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
et
ethically complex situations
etidronate-
etiologic causes
europa
europese society of cardiology guidelines
evaluat
evidence based practice
evidence-based treatments
exercise
exercise adherence
exercise group
exercise performance
exercise programmes
exercise time
exercise training
exertion
expenditure
expenditures
experimental hf
explant-derived progenitor cells
external validity
extracorporeal
extracorporeal membrane oxygenation membrane support
failing fontan
failing heart
failing hearts
familiar physician
families
fat
fat loss
fat mass index
fat-free mass index
fatal
feeding
female
fes group
fetal
fiber
figuur
financial burden
first hf hospitalization
fish lacking nucleolin
fit
fit men
fixed ring size
fixed-rate atrial pacing
flow-mediated dilatation diameter
fluorescence resonance
flutter
follow up body weight
follow-up echocardiograms
follow-up exercise capacity
follow-up measurement
follow-up tests
follow-up visits
fontan adults
force generated
fractal scaling exponent
framingham heart study criteria
free-breathing pulse sequennce
full medicare coverage
function
function in vitro
functional
functional abnormalities
functional class iii hf
functional class nyha ii-iii
functional decline
functional deficits
functional efficacy
furosemide dose
futility
g-protein-coupled receptor kinase-2
gating movement
gdmt-treated nyha functional class iii hf
gem
gene expression profiling
genes coding
genetic susceptibility
genomic reprogramming events
germline dna
global longitudinal strain
global proteomics
glucose transporter
gly16/ glu27 haplotype
glycosylated
goal-directed lipid-lowering therapy
grading of recommendations assessment
gross income
gross national income per capita
gtpase rac1
guideline recommendations in heart failure
guideline-heart failure registry
guideline-mandated usual care
guideline-recommended drugs
guideline-recommended medications
guidelines-heart failure
h
haard ratio
habc battery score
habc battery scores
haemodynamic outcomes
haemodynamic stress
hand
hand grip strength
hand2 in heart failure
handling
hbf
hct chest radiation
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced
hdl-induced no production
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health behaviors
health care expenditures
health insurance
health outcomes
health per capita
health service planning
health service provision
health status
health system data partners
health systems
healthcare programmes
healthcare utilization effects
healthy cardiomyocytes
healthy control
healthy controls
healthy heart muscle cells
heart failure adherence
heart failure admission
heart failure admissions
heart failure clinic
heart failure discharges
heart failure disease management
heart failure disease management programs
heart failure efficacy
heart failure guidelines
heart failure home
heart failure hospitalization
heart failure hospitalizations
heart failure index
heart failure mortality
heart failure nurse practitioner
heart failure nurses
heart failure patients
heart failure prone to ventricular tachycardia
heart failure rats
heart failure risk
heart failure treatment
heart failure-related hospitalization
heart failure-related qol
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heartmate ii devices
heartmate ii exchange
heartmate ii implantation
heartmate ii insertion
heartmate ii lvad
heartware intl
heartware patients
helix-loop-helix
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hemoglobin levels
hemolysis events
hepatic function
heterogenous improvement
hf admissions to acute care hospitals
hf canine electromechanics
hf clinic outpatients
hf cohort
hf complicating ami
hf concurrent
hf cpgs
hf epidemiology
hf hospital admissions
hf hospitalisations
hf hospitalization
hf hospitalizations
hf hospitalized
hf induced in mice
hf met preserved ejection fraction
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf pathophysiology
hf patient plasma
hf patients
hf prediction model
hf progression
hf rats
hf readmissions
hf registry
hf remodeling
hf resources
hf risk
hf risk factors
hf risk prediction
hf studies
hf symptom
hf tissues
hf units
hf volume management
hf-action cohort
hf-induced remodeling
hf-related cachexia
hfpef patients
hfpsi model
hfref therapy
hfvt
hg
hgb level
hhf
high mortality
high-fat diet
high-frequenncy
high-sensitivity assay
high-volume ed cases
high-volume eds
high-volume physicians
hnorm
hnorm group
hoge-density lipoprotein
home telemonitoring
hoog-cost medicare fee-for-service beneficiaries
hospital anxiety and depression scale score
hospital clustering
hospital days
hospital discharge
hospital mortality
hospital performance
hospital quality of care outcomes
hospital rankings
hospital rates
hospital volume
hospitalization for heart failure
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hr dynamics
hr per kg/m
hr variability/turbulence
hr=00.948
hretn
hum- retn mice
hum-retn mice
human heart failure
human hf
human myocardial tissue
human rad q66p
human resistin
human resistin in heart failure
humanized male mice
humanized mouse
humans
humoral stimuli
hvad devices
hybrid system
hypertrophied heart
i
i-meta-iodobenzylguanidine
i-mibg
i-mibg cardiac washout
i-mibg myocardial washout
icd patients
icd-hf patients
icu admission
icu mortality
idiopathic dilated cardiomyopathy cohort
if inhibitor ivabradine trial
il 6
impact
impaired lv relaxation
impaired right ventricular pump function
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implanted left-to-right interatrial shunt
implanted monitoring devices
in vivo inhibition
in vivo rv length-force relationship
in-hospital adverse events
in-patient follow-up
in-trial resource utilization
inactive cxl-1051
inappropriate atp
inappropriate icd shocks
inappropriate implantable cardioverter-defibrillator therapy
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incident cardiovascular events
incident hf
index
index admission
index ami
index beat method
index ed visit
index hf
induce heart failure
inducible myocardial ischemia
industrial areas
infarct size
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin
inflammatory abdominal
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
inhibit cardiac l-type channel activity
inhibiting tgf-β receptor type i
inhibition
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortality
inhospital outcomes
inmuscular testosterone supplementation
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient admissions
inpatient assessments
inpatient medical conditions
inpatient records
inpatients with heart failure
insights
insulin action
insulin receptor substrates
insulin-signaling components
insulin-stimulated rates
insurance status
intact hearts
integrated discrimination
interaction effect
interest
interleukin receptor family member
intermediate frail
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal consistency
internal reliability
interne
interventions
interventricular septum biopsies
intestinal morphology
intl
intracellular antiadrenergic therapeutic strategy
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intravenously injected
intrinsic left ventricular dysfunction
intubation rates
invasive hemodynamic
ip
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 in the heart
irs2 proteins
is
ischemic etiology
ischemic hf pathogenesis
ischemic right heart failure
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isolated lvad
isolated pump replacement
isoprenaline infusion
iv heart failure
iv hf
ivabradine group
ivabradine unloads
ivabradine-
japanese heart failure patients
jehovah
joanna briggs institut
kaiser permanente northern california
kansas city cardiomyopathy questionnaire summary
kcal
kccq domains
kccq overall summary
kccq scales
kccq summary scores
kcl-ki treatment
kidney index score
kidney injury
kir
knockdown
kosten
kosten-efectiveness model
kosten-effectiveness
kv4.3 channel mrnas
kv4.3 mrna levels
kwt
l-dko mice
l-type ca2(+)
l-type channel inhibition
l-type channel isoforms
label-free shotgun proteomics
laboratory report
lack of hypertension
lancet
lateral wall
lb
lc-ms
lcx model
leaflet motion
leaflet repair
leaflet resection
lean
lean body mass ratio
lean zsf
left
left main
left ventricular assist device implantation
left ventricular biopsies
left ventricular ejection
left ventricular filling pressure response
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular systolic
left ventricular tissue
left-hand grip
left-to-right interatrial shunting
leg strength
length-force relationship
leu3-gly4
lf
liberal transfusion protocols
life-sustaining treatment
lipoprotein functional properties
littermate controls
load-corrected chronotropic response
log2
logistic regression analysis
logistic regression models
lokomat® system
long-acting insulin products
long-term mortality
long-term survival
long-term ventricular assist device
longitudinal outcome-monitoring phase
longitudinal strain
low bp
low left ventricular ejection fraction
low left ventricular ejection fractions
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequenncy
low-volume ed cases
low-volume eds
low-volume physicians
lower body mass index
lower cd34+vegfr2
lower exercise performance
lower limbs
lower mortality
lp-pla2]
lung weight
lv end systolic volume index
lv posterior wall thickness
lv structure
lv systolic dysfunction
lvad implantation
lvad insertion
lvet carries
lying
m
madit-cr
madit-crt trial
magnet(®
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated rotor
main outcome
main outcome measure
maladaptive cardiac remodelling
maladaptive molecular processes
maladaptive remodelling
male gender
male sex
malfunctioning heartmate ii lvads
malignancies
management
management strategies
mandatory
markers
mass
mdc95%
mean ejection fraction
mean pressure gradient
measuring np levels
mechanical
mechanical cardiac
mechanical dyssynchrony
mechanical support devices
mechanism
mechanism of action
mechanisms
mechanisms of disease
mechanistic insight
median age
median bnp
median body mass index
median egfr
median followup
median left ventricular ejection fraction
medicaid services
medical hospitalization
medical management
medical outcomes study short-form quality of life domains
medical records
medical resource
medical support
medical therapies
medical treatment guidelines
medically managed diseases
medicare beneficiaries
medicare data
medicare fee-for-service
medicare fee-for-service beneficiaries
medicare hospital claims
medicare inpatient data
medication regimen
mediterranean
mediterranean diet scores
medium
men
mesenchymal transition markers
metabolic abnormalities
metabolic enzymes
metabolic risk factors
metoprolol treatment
metric choice
mi animals
mi diagnosed
mice
microarray data
mid lad
middle-aged recreational athletes
midwestern state
mild disease
mild mr
minnesota living with heart failure
mir-25 expression integrate
mistargeting
mitochondrial damage
mitochondrial oxidative stress
mitochondrial proteome changes
mitochondrial ultrastructural
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral filling flow volume
mitral stenosis reversed
ml
ml/kg/min
ml/m2
mlhf
mlhf total score
moderate to severe heart failure
modifiable risk factors
molecular biomarkers
molecular level
molecular mechanism
morpholino-based knockdown
mouse heart
mouse heart failure
mouse hearts
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mri-based models
mrna level
mrna levels
mt
multicenter automatic defibrillator implantation
multimarker-based strategy
multiparametric echocardiographic score
multivariable cox modeling
murine equivalent
murine myocardium to heart failure
murine resistin
muscle strength
muscle strip stiffness
muscle strips
muscle wasting
muscle-wasting syndrome
muscular strength
mutant mice overexpressing hand2
myocardial delayed enhancement imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial titin hypophosphorylation
myocardium displays
myocyte diameter
myocyte hypertrophy antecedent to heart failure
myofiber
myofiber shortening velocity
myofibrillar ca(2+)-stimulated atpase activity
n-terminal fragment
n-terminal pro-brain-type natriuretic peptide assessment
na+ channel mrna splice
na+ channel mrna splice variants
na+ current
nad(ph-oxidase subunit rac2
nanomolar doses
national cardiovascular disease registry
natriuretic peptide levels
natriuretic peptide system
negative coronary angiography
negative cross talk
negative predictive value
neonatal rat ventricular cardiomyocytes
neprilysin blocks
neprilysin inhibitor prodrug
nesiritide strategy
net economic savings
net reclassification
network meta-analysis
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new york heart association class i to iii
new york heart association class iii heart failure
nfat signalling
nicorandil ameliorates mitochondrial dysfunction
nights spent in hospital
ninth revision
nitric oxide donors
nmol/l
no production
noc outcomes
non-aas
non-diabetic patients
non-diastolic abnormalities
non-dnx
non-fatal stroke
non-frail participants
non-hf populations
non-ischemic
non-ischemic heart failure samples
non-lbbb
non-linear
non-linear hr variability
non-sudden cardiac death
non-survivors
nonadherence
noncardiac
noncardiologist physicians
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nondiabetic patients
nonfatal
nonfunctional channels
noninvasive surrogates
nonmitochondrial protein changes
nonpace
nonpace dnx
nonselective
nonsurvivors
nontraumatic death
nontreatment
nordic walking
norepinephrine-induced hypertrophic
normal geometry
northwest united states
np assessment
np levels
np measurement
nt-probnp assay
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nurse assessment
nurse leaders
nursing management
nursing terminologies
nursing-sensitive outcome change scores
nursing-sensitive outcome measures
nutrition
nutritional strategies
nuts
nyha functional assessment
nyha functional class ranking
o-1 signaling
o2 consumption rate
obese body mass index
obese men
obese older patients
obese participants
obese zsf
obese zsf1
odds
ods ratio
off-pump
oht bridged to transplant
older adults
older adults hospitalized
older athletes
older patients
older patients with heart failure
open chest model
open stent
open surgery
open-label crossover study
opening
optimal diuretic therapy
oral glucocorticoid dosage
oral glucocorticoids
organic lesion
organisation of care taxonomy
outpatient models
outpatient settings
overexpress scn5a variants
overstimulation
overweight
overweight body mass index
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
oxygen uptake
p. arg83gly
p38alpha mapk
p38α mitogen-activated protein kinase
pace
pace non-dnx
paced myocardium
paediatric cardiac transplants
paediatric heart failure
paf biosynthetic enzymes
paf levels
paradigm shift
parasympathetic function
partial pressure
participatory
passive
patent
pathological cardiac gene expression programme
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathological stress
pathophysiologic mechanism
pathophysiologic mechanisms
pathophysiological origin
pathway analysis
patient compliance
patient consultation
patient management interventions in heart failure
patient preferences
patient safety
patient safety initiatives
patients admitted to ed
patients discharged
patients hospitalized
patients hospitalized with heart failure
patients in heart failure
patients undergoing vad
patients with heart disease
patients with heart failure
patients without diabetes
pb cycle
pde2 activity
pde2 expression
pde2 overexpression
pde2)
pde2-mediated effects
pde2-overexpressing cardiomyocytes
peak o2 per kilogram
pediatric heart failure
pediatric mechanical cardiac support
pediatrics
penalties
percutaneous coronary revascularization
percutaneous one-vesel model
percutaneous revascularization
performance
periprocedural
perk activation destabilized scn5a
perk inhibition
permanent periodic breathing
permeability
perturbations
perturbed mitochondrial function
pevk segment
pf cohort
pf-ah
pf-cpt
pharmaceutically assisted
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
phosphomimic ser77
physical activity
physical exhaustion
physician adherence
physician continuity
physician follow-up
physician volume
physio ring
physiologic processes
physiological proteolysis
pigs
pka subunits
pkc-βii-ser
plasma collected
plasma samples
plasticity
pluripotency marker nanog
poc measurement
poc systems
poc technology
point-of-care systems
polytetrafluoroethylene tube
porcine model
positron emission tomography imaging
post myocardial infarction
post- lvad ai
post-acute care transfer policy
post-dash
post-hct chf
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
post-tac cardiac functional deterioration
post-translational modification
post-transplant morbidity
post-transplant mortality
postcontrast
posteriorly displaced papillary muscles
postmarketing
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
postoperative survival
postystolic function
practice innovation
pre-crt lv
pre-hct exposure to anthracyclines
pre-pd
prediction rule
predictor
predictors
preoperative albumin
preoperative hypoalbuminemia
preserved
preserved cardiac index
preserved left ventricular
preserved left ventricular ejection
preserved mitral valve opening
preserved systolic function
pressure
pressure gradient
pressure-overload-induced hypertrophy
pressure-volume conductance
prevention strategies
prior stroke score
priorities
pro6-gly7
proangiogenic effects
process redesign
prognostic benefit
prognostic power
programmed cell death
progression to heart failure
progressive disease
prolonged electromechanical delay
propensity
propensity score decile
prostate
protective effects
protective peptides
protein content
protein levels
protocol-driven poc testing
proximal circumflex artery
proximal lad
proximal lcx
proximal left anterior descending
proximal left anterior descending artery
ps
psoriasis patients
psychometric profile
psychometric testing
psychosocial factors
public health
public health problem
public reporting
pulmonary arterial hypertension medication
pulmonary artery snared
pulmonary hypertension patients
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pump replacement
pure epicatechin
pure hno donor
q65p substitution
qrs width
quadriceps force
quality
quality improvement database
quality of life score
quality-of-life score
quality-of-life scores
quantitative proteomics
québec health insurance board databases
r-like er kinase
r-r interval oscillations
r. cluster analysis
r13058338
rabbits
race
rad on cav1.2
rad q65p
rad q66p
radial artery tonometry
radioenzymatic-
raf-mek1/2-erk1/2 signalling
raised blood glucose levels
raloxifene-treated
rapid right ventricular pacing
ras-
ras-blocker uptitration
rat
rat metabolic risk
rate-control patients
rate-control strategies
rate-control treatment strategies
ratio ees
ratios
rats
readmission metric
readmission metrics
readmission rate
readmission rates
readmission reduction program
readmission to hospital
receiver operating characteristic curve
recent findings
recipients
reciprocal downregulation
reciprocal regulation
reclassification
recovery
reduced
reduced ejection
reduced mortality
reducing mortality
refill compliance
refractory
regulation
regulatory
regulatory subunit
relaxation
religious beliefs
remove heart iron
renal atherosclerotic lesions
repeat ed visits
reperfusion therapy
repolarization instability
repolarization lability
residual confounding
resistance training
resistin levels
resource use
respiratory
response
responsiveheid to clinical change
restoration
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
retention trial
retn gene
reverse cardiac remodeling
reverse remodeling parameters
reversibility
reversible myocardial ischemia
rhythm
rhythm- and rate-control strategies
right atrial area
right atrial mass removal
right atrium mass
right grip strength
right ventricle overload
right ventricular contractile
risk
risk factors
risk of death
risk predictor
risk reduction
risk-adjusted all-cause mortality
risk-adjusted mortality
risk-standardized mortality
riα proteins
rm strategies
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rotterdam
rr intervals
rural south dakota
rv failure management
rv function evaluation
s'lateral
s'septal
s1pr
s1pr1 cardiac gene therapy
sarcomere length relations
sarcomere shortening
sarcopenic range
schfi
sci
science
scientific literature
scn5a transcript
score
screening
sd decrease
sd testosterone levels
sdqt-to-sdrr ratio
seattle heart failure model-predicted survival
self-care
self-care confidence scale
self-care maintenance scale
self-care management scale
self-care of heart failure index
self-management counseling
self-reported physical activity
septal defects
septal wall cs
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant
ser83 phosphorylation
ser96)
serum creatinine level
serum factors
serum potassium level
serum resistin
severe cad
severe end-stage hf
severe frailty
severe hyperkalemia
severe hypertension
severe hyponatremia
severely reduced lvef
sex
sham
sham explants
sham group
sham levels
sham-dnx
sham-innervated
sham-inv
sham-operated
sham-operated animals
shams
sheet orientation
short-term mortality rates
shortened lvet
shortness
shotgun
shunt implantation
shunt implants
signal transduction cascade
signalling cascades
signalling pathways activating
simulation models
simulations
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass correlated
skeletal muscle sarcomere structure
skilled nursing facilities
skinfold thickness
skm biopsies
skm growth
skm mitochondrial structure
slow hf
slowed conduction
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
snared to decrease co
snp rs10927887
social mandate
social support
socioeconomic status
sodium levels
sodium restriction
sodium-restricted dash diet
sodium-restricted dietary approaches
soluble
soluble guanylate cyclase
soluble st2
southeastern minnesota residents
sp2
sphingosine-1-phosphate receptor
spironolactone dose
spontaneous cardiac dysfunction
sprague- dawley rats
sr ca(2+)-pump function
srd
srd brachial
sst2 concentrations
sst2 measurement
sst2 status
sst2 titrated to high-dose bb
sst2/high-dose bb
sst2/low-dose bb
st2 level
st2 levels
stabilized chronic heart failure
stable coronary artery disease
stable heart failure patients
stable hfpef
stage i-iii breast cancer
stand-alone diagnostic devices
standard cardiac rehabilitation
standard error
standard heart failure medicines
standing blood pressure
statitistical significance
ste analysis
stem cell source
stent coated
stent occlusion
sterf
sternal sparing approach
stiffness
stockholm
stop hypertension diet
strain rate
stress
stress conditions
stretch rate
stroke prevention trial
strong acid
structural heart disease
structurally normal hearts
structured exercise programme
sts hh
sts hm
study design
subcellular alterations
subclinical atherosclerosis
subunit expression
suburban hospitals
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
surgical conditions
surgical indication
surgical method
surgical patients
surgical revascularization
surgical ring implantation
surgical tactics
surgically induced myocardial infarction
survival
survival study
survival study in heart failure
survival to hospital discharge
sustainability
svr index
swedish national inpatient registry
swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies registry
swine
swine model
sympathetic control
symptom limited
systematic monitoring
systematic review
systematic review protocol
systemic/uv treatment
systolic dysfunction treatment
systolic heart failure treatment
systolic human heart failure
systolic indices
systolic left v entricular dysfunction
t1-mapping values
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
taxonomy
techniek
tertiary referral centre
testosterone group
testosterone status
texas cancer registry–medicare databases
tgf-β inhibition
tgtetmena
tgtetmena mice
thalassaemia
therapeutic functions
therapeutic interruption
therapeutic left-to-right interatrial shunting
therapeutic strategy
therapeutic targets
therapeutic treatments
therapy refractory cardiogenic shock
thickness
thigh muscle
time domain heart rate variability
time to death
time to esrd
tissue
tissuefaxs technology
titin isoforms
titin modification
tm interventions
to death
tobacco
tools for economic analysis of patient management interventions in heart failure
total adiponectin
total cholesterol
total myosin binding protein-c phosphorylation
total symptom domains
toxicity
trans
transcription
transcription factor dhand
transcriptional analysis
transduction
transforming growth factor beta-dependent yield
transfusion thresholds
transgenic mice
translational repression
transmitral e-wave
transmitral flow velocities
transoesophageal echocardiographic guidance
transplant ineligible patients
transplant pool
transplant-ineligible patients
transplantation eligibility status
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treating advanced hf
treatment
treatment for heart failure
treatment group
treatment group effects
trial
trial investigating outcomes
trial investigating outcomes of exercise training
trigger hemoglobin threshold
trpm7) channel mrna
truncated na+ channels activate
tta
tta/tgtetmena mice
tunel assay
twist
two-vessel disease model
type ii regulatory
u.s. food and drug administration
ultrastructural
um cohort
um/va/va-rt
um/va/va-rt cohorts
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
unfamiliar physician
unfavorable outcome
unfit
unfit men
unilateral
unit costs
university of michigan hf clinic
unloading
unplanned readmission
untreated acf groups
upr effectors
urban academic medical center
urgent all-cause readmission
urgent cardiac transplant
urgent readmission
va cohort
va patients
va-rt cohort
vad group
vad groups
vagal
variability
vascular effects
vascular endothelial growth factor protein
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
vegetables
vegfr2
vehicle
vehicle-treated rats
velocity
velocity time integral
ven
venous thrombolic events
ventricular action potential duration
ventricular assist device support
ventricular contractile reserve
ventricular dilatation
ventricular ejection
ventricular ejection fraction
ventricular structure
ventricular systolic hf tissue samples
ventricular wall stress
ventricularly paced
virtual cohorts
viscoelastic
vivo phosphorylation sites
voltage-gated ca(2+) channels
voltage-gated cardiac na+ channel α-subunit
volume eds
voordeel
voordelen
waist circumference
walk test distance
water
weak grip strength
weekly trastuzumab
weight
weight loss
western australian linked administrative health
western blot analysis
western society
wha class iii
white
whites
whole grain intake
wilcoxon
wild type
wild-type littermates
wind failure
wistar rats
witness
women
womens health initiative
world health organization criteria
worsening heart failure
worsening renal function
wr
wrf
writer
wstar-kyoto
wt
wt riα
xo-mediated ros effects
yorkshire swine
zebrafish
zsf1 group
zsf1 groups
zsf1 rats
zung
β-adrenergic receptor activation
β-adrenergic receptor stimulation
β-ar stimulation
β-blocker dose
β-blocker dose changes
β-blocker metoprolol
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers therapy
β1ar downregulation
β2-receptor haplotype status
